Evaluation of a patient medication profile based on the use of duplicate labels

International Health Care and Pharmacy: Current Implications With Particular Reference to Developing Communities

“…In SA, for example, the first two items have been combined in Schedule 3 of the Medicines Control Act [60] , in which prescription medication for certain chronic conditions may be repeated to a maximum period of 6 months at the pharmacist's discretion. The third element is based on the emergence of biopharmaceutics as a precise science [61], The fourth need not be as costly as might be imagined as inexpensive duplicate label systems have already appeared [62] [63] . They do not require skilled personnel to maintain.…”